- Home
- APLS vs ENLT Comparison
APLS vs ENLT Comparison
Compare APLS & ENLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- ENLT
- Stock Information
- Founded
- APLS 2009
- ENLT 2008
- Country
- APLS United States
- ENLT Israel
- Employees
- APLS N/A
- ENLT N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- ENLT
- Sector
- APLS Health Care
- ENLT
- Exchange
- APLS Nasdaq
- ENLT Nasdaq
- Market Cap
- APLS 2.2B
- ENLT 3.0B
- IPO Year
- APLS 2017
- ENLT 2023
- Fundamental
- Price
- APLS $19.20
- ENLT $24.42
- Analyst Decision
- APLS Buy
- ENLT Buy
- Analyst Count
- APLS 19
- ENLT 4
- Target Price
- APLS $37.89
- ENLT $21.75
- AVG Volume (30 Days)
- APLS 2.2M
- ENLT 29.6K
- Earning Date
- APLS 07-31-2025
- ENLT 08-06-2025
- Dividend Yield
- APLS N/A
- ENLT N/A
- EPS Growth
- APLS N/A
- ENLT 90.47
- EPS
- APLS N/A
- ENLT 0.98
- Revenue
- APLS $775,839,000.00
- ENLT $397,296,000.00
- Revenue This Year
- APLS $10.84
- ENLT $355.90
- Revenue Next Year
- APLS $10.51
- ENLT $42.83
- P/E Ratio
- APLS N/A
- ENLT $25.82
- Revenue Growth
- APLS 48.04
- ENLT 44.42
- 52 Week Low
- APLS $16.10
- ENLT $14.01
- 52 Week High
- APLS $41.94
- ENLT $27.16
- Technical
- Relative Strength Index (RSI)
- APLS 49.02
- ENLT 49.66
- Support Level
- APLS $19.16
- ENLT $24.91
- Resistance Level
- APLS $20.40
- ENLT $25.44
- Average True Range (ATR)
- APLS 0.95
- ENLT 0.38
- MACD
- APLS -0.06
- ENLT -0.31
- Stochastic Oscillator
- APLS 22.12
- ENLT 1.68
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About ENLT Enlight Renewable Energy Ltd.
Enlight Renewable Energy Ltd develops, finances, constructs, owns, and operates utility-scale renewable energy projects. The company's operating segments are the MENA segment, Europe segment, U.S.A segment, and Others. It generates the majority of its revenue from the Europe segment, which produces its revenue from the sale of the electricity that is produced through wind energy and solar energy in Europe.